Status of the SIRGAS reference frame: recent developments and new challenges

Autor: Martínez W., Mackern M.V, Drewes H., Rovera H., Brunini C., Sánchez L., Fortes L.P.S, Lauría E., Cioce V., Pérez R., de Freitas S.R.C, Costa S.M.A, Hoyer M., Luz R.T, Barriga R., Subiza W.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______518::e202bd78e0ba6454831a176e7a9bcd48
https://mediatum.ub.tum.de/1537757

Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults.

Autor: Oshansky CM; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., King J; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Lu D; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Zhou J; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Pavetto C; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Horwith G; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Biscardi K; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Nguyen B; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Treanor JJ; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Chen LM; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Jepson B; Rho, Inc., Durham, NC, USA., Bright RA; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Johnson RA; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Cioce V; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Donis RO; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA. ruben.donis@hhs.gov.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2021 Mar 19; Vol. 6 (1), pp. 41. Date of Electronic Publication: 2021 Mar 19.

Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).

Autor: Oshansky CM; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Zhou J; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Gao Y; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Schweinle JE; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Biscardi K; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., DeBeauchamp J; St. Jude Children's Research Hospital, Memphis, TN, USA., Pavetto C; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Wollish A; PPD, Wilmington, NC, USA., Webby RJ; St. Jude Children's Research Hospital, Memphis, TN, USA., Cioce V; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA. Electronic address: vittoria.cioce@hhs.gov., Donis RO; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA. Electronic address: ruben.donis@hhs.gov., Bright RA; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA.

Publikováno v: Vaccine [Vaccine] 2019 Jan 14; Vol. 37 (3), pp. 435-443. Date of Electronic Publication: 2018 Dec 12.

Combining High Resolution Global Geopotential and Terrain Models to Increase National and Regional Geoid Determinations, Maracaibo Lake and Venezuelan Andes Case Study.

Autor: Wildermann, E., Royero, G., Bacaicoa, L., Cioce, V., Acuña, G., Codallo, H., León, J., Barrios, M., Hoyer, M.

Publikováno v: Geodesy for Planet Earth; 2012, p901-907, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.